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Objectives. We sought to analyze risk factors for long-term
survival (up to 36 years) after surgical repair of tetralogy of Fallot
(TOF).
Background. Survival after repair is excellent, but data >20
years are rare.
Methods. From 1958 to 1977, 658 patients underwent correction
of TOF at our institution and were analyzed for survival. Of this
patient group (age 12.2 6 8.6 years [mean 6 SD], range 2 to 67),
39.7% had a previous palliation. Operative (n 5 139) and 1-year
(n 5 29) deaths were excluded for long-term calculations, result-
ing in a study group of 490 patients.
Results. Actuarial 10-, 20-, 30- and 36-year survival rates were
97%, 94%, 89% and 85%, respectively. Mortality increased 25
years postoperatively from 0.24%/year to 0.94%/year (p 5 0.003).
The most common cause of death was sudden death (n 5 13),
followed by congestive heart failure (n 5 6). Multivariate corre-
lates of impaired long-term survival were date of operation (before
1970, p 5 0.0104), preoperative polycythemia (p 5 0.0487) and
use of a right ventricular (RV) outflow patch (p 5 0.0079).
Postoperative systolic RV/left ventricular pressure ratio and age
showed no influence. Patients without preoperative polycythemia
and an RV outflow patch (n 5 164) had a 36-year actuarial
survival rate of 96% and normal life expectancy.
Conclusions. Cyanosis, operative experience of the surgeon and
an RV outflow tract patch influence long-term outcome after
repair of TOF in older children. Early repair by experienced
surgeons to avoid polycythemia and excessive RV hypertrophy is
supported by this study. However, mortality risk increases 25
years postoperatively, and thus heart monitoring should be inten-
sified.
(J Am Coll Cardiol 1997;30:1374–83)
©1997 by the American College of Cardiology
On August 31, 1954, Walton C. Lillehei attempted the first
operative correction of tetralogy of Fallot (TOF), the most
common cause of cyanotic congenital heart disease (1). Since
that time, operative mortality has decreased dramatically, and
correction is now usually performed in infancy or early child-
hood (2). Thus, the adverse long-term effects of cyanosis and
chronic hypoxia are avoided, but the use of an outflow tract
patch is more common in some centers (3). Long-term survival
is reported to be excellent but still lower than that of the
normal population (4). However, it remains uncertain whether
these results last for a lifetime and whether subgroups of
patients may achieve normal life expectancy (5).
This study reviews our historic (1958 to 1977) long-term
experience in the correction of TOF and pulmonary stenosis in
739 patients. Correction was performed predominantly in
children 10 years old, and previous palliation was common.
The large patient group is homogeneous because mainly all
patients were operated on by one surgeon (W.K.) using the
same technique, without changes in operative management.
Therefore, risk factors can be analyzed in large subgroups in
which significant differences can be demonstrated. Special
attention was paid to the factors that are believed to influence
long-term survival: age at the time of operation, the presence
of earlier palliative operation, the degree of preoperative
cyanosis, the need for and type of outflow tract enlargement
and the postoperative right ventricular/left ventricular (RV/
LV) systolic pressure ratio.
Methods
Patients. From December 1958 to May 1977, 739 patients
with the diagnosis of TOF with pulmonary stenosis underwent
complete surgical repair at the Clinic of Cardiac Surgery at the
University of Munich. This period was chosen because only a
single surgeon (W.K.) had operated on the vast majority of
these patients, minimizing differences in surgical technique.
Patients with other complex congenital heart lesions were
excluded (e.g., pulmonary atresia, double-outlet RV). We
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attempted to contact all patients who survived the immediate
postoperative period. We were unable to locate 16 of them
(follow-up complete in 98%), but information from the Ger-
man Resident Registry (Einwohnermeldeamt) indicated that
they were alive at least 12 years after the operation. All
foreigners (n 5 52), as well as those known to have moved
outside of Germany (n 5 13), were excluded from follow-up.
Figure 1 shows the overall survival of these patients. To
analyze the factors that influence long-term survival, we ex-
cluded the steep, nonlinear, first phase of the survival curve.
The curve becomes linear after 1 year; therefore, all patients
who died within the 30-day (n 5 139 [19%]) and 1-year (n 5
29 [4%]) postoperative period were separated for further
long-term survival analyses. Table 1 shows a survey of patient
characteristics, including concomitant heart malformations
and previous palliative operations.
Operative methods. All operations were performed using
extracorporeal circulation (ECC) and moderate hypothermia
(28° to 30°C). In the first operations, a Kay-Ga¨rtner screen
oxygenator was used, which was replaced in later procedures
by a Travenol or Bentley bubble oxygenator. The intracardiac
correction was performed through a horizontal RV incision.
However, if the decision was made to use an outflow tract
patch, a vertical incision was made. Outflow tract patches were
used in either the subvalvular (preserving pulmonary valve
competence) or transvalvular (including splitting of the valvu-
lar ring) position. A concomitant patent foramen ovale (PFO)
was left open while all other accompanying defects were
corrected (including a type II atrial septal defect [ASD II]).
During the intracardiac maneuver, the aorta remained
clamped for 24 6 10 min (mean 6 SD); the average bypass
time was 52 6 16 min. A cardioplegic solution was not used in
any of the procedures.
Follow-up and statistical methods. Follow-up was con-
ducted between 1994 and 1995 and consisted of a written
questionnaire. In cases where the patient did not answer
repeated letters, telephone interviews were used. We asked the
patients about their functional status, the occurrence of car-
diovascular events (stroke, transient ischemic events, myocar-
dial infarction, infective endocarditis, arrhythmias, pacemaker
implantation, cardiac catheterization and reoperation), con-
comitant diseases, hospital admittance, use of drugs, physical
activity and occupational status. If a patient died, the closest
living relative and the patient’s physician were contacted to
evaluate the cause of death.
To calculate the influence of variables on operative and
1-year survival, univariate comparisons were carried out using
the two-tailed chi-square test with the Yates correction for
discrete variables. Whenever necessary, the Fisher exact test
was used. Multivariate analyses were performed by multivari-
ate analysis of variance.
Figure 1. Survival after correction of TOF. The first, steep phase of
the survival curve lasts ;1 year. After that time, the curve becomes
linear. Each step in the curve denotes an event, and at each event the
standard error is indicated by vertical bars. OP 5 operation.
Table 1. Preoperative Data
All Pts
(n 5 658)
30-Day
Survivors
(n 5 519)
1-Year
Survivors
(n 5 490)
Age (yr) 12.2 6 8.6 12.1 6 8.2 11.8 6 8.0
Weight (kg) 31.0 6 16.6 31.5 6 16.7 30.6 6 15.2
Height (cm) 133 6 21.9 134 6 21 134 6 21
Female 45% 44% 45%
Preop HCT (%) 54 6 12 53 6 12 53 6 12
Preop erythrocytes (106/dl) 6.0 6 2.62 5.76 6 1.76 5.72 6 1.78
Prev palliative op
Modified B-T shunt 188 (29.4%) 140 (26.9%) 136 (27.8%)
Central shunt 11 (1.7%) 7 (1.3%) 6 (1.2%)
Brock’s op 65 (10.2%) 56 (10.8%) 51 (10.4%)
1 prev op 231 (36.1%) 175 (33.7%) 166 (33.9%)
2 prev op 22 (3.4%) 16 (3.1%) 15 (3.1%)
3 prev op 1 (0.2%) 1 (0.2%) 0
Concomitant cardiac
malformations
ASD I 1 (0.2%) 0 0
ASD II 65 (10.2%) 51 (9.8%) 45 (9.2%)
PFO 129 (20.2%) 112 (21.5%) 108 (22%)
Situs inversus 4 (0.8%) 3 (0.6%) 3 (0.6%)
Left SVC 20 (3.1%) 12 (2.3%) 12 (2.4%)
Multiple VSD 2 (0.4%) 0 0
Data presented are mean value 6 SD or number (%) of patients. ASD 5
atrial septal defect; B-T 5 Blalock-Taussig; HCT 5 hematocrit; op 5 operation,
operations; PFO 5 patent foramen ovale; Preop 5 preoperative; Prev 5
previous; Pts 5 patients; SVC 5 superior vena cava; VSD 5 ventricular septal
defect.
Abbreviations and Acronyms
ASD 5 atrial septal defect
AV 5 atrioventricular
ECC 5 extracorporeal circulation
HCT 5 hematocrit
LV 5 left ventricle, left ventricular
PFO 5 patent foramen ovale
RV 5 right ventricle, right ventricular
TOF 5 tetralogy of Fallot
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The probability of long-term survival was estimated using
the Kaplan-Meier method. Differences between groups were
calculated by the log-rank test. The survival curve was com-
pared with the expected curves of persons of the same age and
gender born at the same time, as derived from the Landesamt
fu¨r Statistik of Bavaria, Germany. The association of variables
to long-term survival was first tested in an univariate model.
Every univariate variable reaching or approaching significance
(p , 0.1) was then tested in a Cox multivariate model and
removed stepwise if no significant influence was proved. Sta-
tistical analyses were facilitated with the help of SPSS statisti-
cal software (SPSS Inc.).
Results
Overall survival. The mean duration of follow-up was 25.3
years (median 25.4, range 1.06 to 35.5). Actuarial 10-, 20-, 30-
and 36-year survival rates in the 490 patients who survived the
first postoperative year were 97%, 94%, 89% and 85%,
respectively. Long-term survival was excellent but still signifi-
cantly lower than that in the normal population (p , 0.001).
Mortality was linear in the first 25 years after the operation and
equaled 0.24% per year. Thereafter, it increased significantly
to 0.94%/year (p 5 0.003) (Fig. 2). During the long-term
follow-up period, 42 patients died, most from cardiac causes
(n 5 26 [62%]). Table 2 describes the causes of late death and
the time of their occurrence in detail.
Analysis of risk factors. Many preoperative and postoper-
ative factors were tested for whether they influenced operative
and 1-year mortality or late survival. Table 3 shows the most
important results for short-term survival. Univariate correlates
of adversely affected long-term survival included use of an
pulmonary outflow patch (p 5 0.0002), longer duration of
cardiopulmonary bypass (p 5 0.023), presence of an ASD II
(p 5 0.017), preoperative polycythemia (p 5 0.036), no
palliative operation (p 5 0.046) and date of operation (better
outcome for patients operated on in the 1970s; p 5 0.026). On
multivariate analysis, only date of operation (p 5 0.0104),
preoperative polycythemia (p 5 0.0487) and use of a pulmo-
nary outflow patch (p 5 0.0079) correlated with the outcome.
Table 4 shows the results of univariate and multivariate
analyses of long-term survival.
Survival according to age at operation. Survivors of the
first year were classified into four age categories: ,6 years old
at date of operation (n 5 46); 6 to 10 years old (n 5 240); 11
to 20 years old (n 5 139); and .20 years old (n 5 64). Their
35-year survival rates were 91.3%, 91.9%, 87.8% and 72.1%
Figure 2. Long-term survival after correction of TOF. All patients who
died within the first year after correction were excluded for calculation
of long-term survival. The curve shows two different phases that are
distinct. The early, low risk phase lasts 25 years; thereafter, the risk
increases significantly. Mortality risk (r) per year, as a linearized
number, is calculated for each phase. Note the break in the y axis.
OP 5 operation; p.o. 5 postoperatively.
Table 2. Causes of Death During Long-Term Survival
No. (%) of Pts
Who Died Pt Age at Death (yr) Postoperative Death (mo)
Cardiac causes 26 (61.9%)
Sudden cardiac death 15 (35.7%) 13, 15, 15, 18, 21, 22, 24, 25, 32,
33, 34, 34, 34, 37, 45
38, 83, 91, 98, 110, 122, 153, 156, 162,
169, 256, 305, 307, 346
CHF 6 (14.3%) 13, 13, 17, 28, 37, 64 13, 22, 30, 79, 122, 356
MI 2 (4.8%) 59, 65 260, 403
RV aneurysm 1 (24%) 34 309
Reoperation 1 (2.4%) 21 203
Recurrent VSD 1 (2.4%) 22 107
Noncardiac causes 8 (19%)
Suicide 2 (4.8%) 19, 35 151, 327
Sepsis 2 (4.8%) 75 238
Brain abcess 1 (2.4%) 27 252
Pneumonia 1 (2.4%) 75 284
Stroke 1 (2.4%) 20 142
Kidney failure 1 (2.4%) 15 80
Unknown* 8 (19%) 19, 25, 27, 29, 41, 44, 59, 66 100, 186, 198, 207, 257, 310, 314, 426
*In two patients, suicide was likely but not confirmed. CHF 5 congestive heart failure; MI 5 myocardial infarction;
Pt 5 patient; RV 5 right ventricular; other abbreviations as in Table 1.
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years, respectively. No significant differences could be detected
between the groups (Fig. 3).
Survival according to previous palliative operations. More
than one-third of the patient group (n 5 181 [36.9%]) had at
least one previous operation (Table 1). The mean age at the
time of palliation was 6.0 6 7.5 years, and the interval to
definitive correction was 4.6 6 2.5 years. Statistics for differ-
ences in long-term survival with one and more previous
operations or different previous palliative operations (periph-
eral shunt, central shunt or Brock’s operation) were not
calculated because of the insufficient number of patients.
Although patients with a previous operation had a higher
mortality rate during the first postoperative year (80.2% vs.
71.3%, p 5 0.013), the long-term outcome in this group was
favorable according to univariate analysis, with a 35-year
survival rate of 90.1% compared with 83.3% in the nonpalli-
ated group (p 5 0.048) (Fig. 4). Multivariate analysis showed
no significant influence of a previous palliative procedure on
long-term survival because this factor was highly intercorre-
lated (p , 0.01) with the preoperative hematocrit (HCT) value
(see subsequent discussion).
Survival according to preoperative polycythemia. Patients
were divided into two groups according to whether their
preoperative HCT level was normal (HCT #48%) or not
normal (HCT .48%). Patients without preoperative polycy-
themia had better operative as well as long-term survival
(Tables 3 and 4 and Fig. 5). Patients with moderate (HCT
between 49% and 59%) and severe (HCT .60%) polycythe-
mia had no differences in their long-term survival.
Survival according to the systolic RV/LV ratio after repair.
The results of intraoperative and postoperative measurements
of RV and LV pressures were available in 585 patients
(88.9%). Patients with an increased RV/LV pressure ratio
(.0.5) had a considerably higher mortality risk within the first
year (Table 3), independent of transannular patching. How-
ever, long-term survival was not affected (Table 4), even if the
ratio was substantially increased (.0.7). In fact, patients with
an RV/LV ratio .0.7 had a 35-year long-term survival rate of
94.4% compared with 83.7% in patients with a lower ratio.
However, this difference was not significant (Fig. 6). Only five
long-term survivors with a transannular patch had an RV/LV
pressure ratio .0.7. Therefore, the data are insufficient to
calculate whether high pressure ratios are less tolerated in the
presence of pulmonary valve insufficiency.
Figure 3. Long-term survival according to patient age at the time of
the operation. Long-term survivors were divided into four different age
groups. All differences between the groups were not significant. OP 5
operation.
Table 4. Risk Factors for Long-Term Survival
Variable* Definition of Groups
Favorable Long-Term
Survival
Data Available
(n)
Long-Term Survival
(n 5 490)
Univariate
p Value
Multivariate
p Value
Age #10 vs. .10 yr Younger 490 0.072
Gender Female vs. male Female 490 0.147
NYHA class preop I vs. II vs. III vs. IV 489 0.48
Preop polycythemia HCT <48 vs. >48 mg/dl HCT <48 mg/dl 481 0.036 0.049
PFO No PFO vs. PFO 490 0.95
ASD II No ASD II vs. ASD II No ASD II 490 0.017
Left SVC No left SVC vs. left SVC 483 0.94
Situs inversus No situs inversus vs. situs inversus 490 0.58
Prev palliative op No previous palliation vs. palliation Previous palliation 489 0.046
Modified B-T shunt No shunt vs. shunt Shunt 490 0.065
Central shunt No shunt vs. shunt 490 0.52
Brock’s op No Brock vs. Brock 490 0.52
VSD size ,20 vs. .20 mm .20 mm 386 0.45
Outflow tract patch No patch vs. outflow tract patch No patch 490 <0.001 0.008
Degree of hypothermia ,28° vs. .28°C 459 0.33
Bypass time #40 vs. .40 min Shorter bypass time 484 0.023
Date of op Before 1970 vs. 1970 and after 1970 and after 490 0.026 0.010
Postop RV/LV SBP #0.5 vs. .0.5 444 0.73
*Significant influence on survival is indicated by italic (univariate analysis) or boldface type (multivariate analysis). Abbreviations as in Tables 1 to 3.
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Survival according to outflow tract patching. Patients with
a need for transannular patching had significantly worse oper-
ative and 1-year mortality compared with those with a subval-
vular patch or no patch (Table 3). In contrast, long-term
survival was impaired by a patch, independent of its location.
The 35-year long-term survival rates of patients without a
pulmonary outflow tract, those with a patch up to the annulus
and those with a patch through the annulus were 86.2%, 79.9%
and 78.7%, respectively (p , 0.05) (Fig. 7). The presence of an
ASD II was significantly associated with the need for an
outflow tract patch (p , 0.01). Therefore, an ASD II showed
adverse effects on long-term survival on univariate analysis.
These effects were no longer significant on multivariate anal-
ysis.
Survival according to date of operation. To test the hy-
pothesis that the skill of the surgeon affects long-term results,
we classified the patients according to the date of their
operation. The numbers of patients operated on before 1970
(n 5 303) and after 1970 (n 5 335) were approximately equal.
From a retrospective view, operative techniques and manage-
ment apparently did not change during the whole period,
although minor changes cannot be ruled out. However, oper-
ative and 1-year mortality were exactly the same (Table 3), but
long-term survival was significantly improved for patients
operated on during the latter period (Fig. 8).
Survival with diagnosis of “low risk” TOF. Because pre-
operative polycythemia and the need for outflow tract patching
were the only significant patient-related factors on multivariate
analysis, the survival of patients without preoperative polycy-
themia and no need for outflow tract enlargement (n 5 169)
was compared with that of the normal population. No differ-
ence in 35-year long-term survival could be detected (Fig. 9).
Follow-up data. More than 90% of the patients reported
themselves to be in New York Heart Association functional
class I or II at the time of follow-up, 96.5% of whom were in
a better condition than that before the operation. Most
patients were in the workforce (70.8%) or housewives (20.1%);
only 6.1% had retired and 3% were unable to work. However,
32.3% of the patients (n 5 137) reported cardiac symptoms,
mainly signs of congestive heart failure as dyspnea (n 5 119
Figure 5. Long-term survival according to preopera-
tive polycythemia. Patients with normal HCT levels
(#48%) showed improved long-term survival on uni-
variate and multivariate analyses. OP 5 operation.
Figure 4. Survival according to previous palliative op-
erations. Long-term survivors with a previous palliative
operation showed improved long-term survival. Multi-
variate analysis demonstrated that this fact was mainly
due to the reduction of cyanosis. OP 5 operation.
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[26.7%]) or edema (n 5 39 [8.8%]). Arrhythmias were also
commonly reported (n 5 60 [14.2%]). Myocardial infarction
occurred in three patients (0.6%) and one (0.2%) had angina
pectoris. Five patients (1.2%) developed endocarditis and six
(1.4%) had hepatitis. A new heart catheterization was per-
formed in 140 patients (32.9%) and 106 (25%) were taking
medication.
Reoperations with ECC. During the first year, five patients,
and during subsequent long-term follow-up another 31 pa-
tients, had a second operation with ECC, resulting in freedom
from reoperation of 91.8% after 35 years (Fig. 10). The most
common cause of reoperation was a residual or reopened
ventricular septal defect in 29 patients, followed by a combined
VSD with outflow tract restenosis in three patients and sole
restenosis in four patients.
Heart rhythm and implantation of pacemakers. On the
electrocardiogram at discharge, 26 patients (5.3%) had an
atrioventricular (AV) block I, 4 patients had an AV block II
(0.8%) and 3 had an AV block III (0.6%). A pacemaker was
implanted in the immediate postoperative course in 11 patients
with AV block (2.2%). During the follow-up period, another
four patients received a pacemaker.
Discussion
The excellent long-term survival after correction of TOF,
even in the very early years of cardiac surgery, is well recog-
nized (4). However, it remains uncertain whether the results
last longer than 25 years. It has been speculated that RV
failure might occur late after correction (6) and the incidence
of sudden cardiac death, the most common cause of late death
(7), might decrease if patients survive into adulthood (8,9).
Our results show a significant impairment of survival .25 years
postoperatively, and sudden cardiac death remained the major
cause of death in these adult patients. This was not true for
patients without the need for an outflow tract patch and
normal preoperative HCT levels; they achieved normal life
expectancy up to 35 years postoperatively.
Sudden cardiac death during long-term survival. Sudden
cardiac death is mainly attributed to ventricular dysrhythmias
Figure 7. Long-term survival according to an RV outflow
tract patch. In the majority of patients no outflow tract patch
was necessary. If the ring of the pulmonary valve was severely
hypoplastic, a patch through the annulus was used to widen
the outflow tract. In some patients, a patch up to the annulus
but not through it seemed sufficient to relieve obstruction.
OP 5 operation.
Figure 6. Long-term survival according to the postoperative
systolic RV/LV pressure ratio. The RV/LV pressure ratio
showed no influence on long-term survival even if it was
severely increased (RV/LV $0.7). OP 5 operation.
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(10); other less common causes are complete heart block (11)
or sick sinus syndrome. Chronic RV overload due to pulmo-
nary regurgitation is related to diastolic function and correlates
with QRS prolongation, which is the most sensitive predictor
of ventricular arrhythmias (12). Therefore, chronic pulmonary
regurgitation caused by a valveless outflow tract patch may
lead to progressive RV enlargement and sudden cardiac death.
Studies in patients with congenital isolated pulmonary regur-
gitation showed that the RV fails after 40 years of successful
adaptation (13).
Impact of an outflow tract patch on long-term survival.
The influence of an outflow tract patch on long-term survival is
controversial. Kirklin et al. (14), as well as Murphy et al. (4),
could not find any differences in long-term survival between
patients with and without an outflow tract patch. Jonsson and
Ivert (15) and our earlier follow-up data (16) showed contra-
dictory results. In our patients, use of an outflow tract patch
remains to be the most important risk factor for late death.
The average age in the studies of Kirklin (median 5.3 years)
and Murphy (mean 10 years) tends to be lower than that in the
study of Jonsson (median 7 years) and also lower than that in
our study (mean 12.2 years, median 9.2). The same is true for
the preoperative HCT level (see below). This indicates that in
time, the RV might stiffen due to increasing hypertrophy and
becomes less capable of adapting to pulmonary insufficiency.
Another possible explanation for our finding could be the
change in operative approach from a horizontal to a vertical
ventriculotomy whenever an outflow patch was deemed neces-
sary. It has been shown that the technique of cardiotomy
significantly effects RV enlargements and consequent arrhyth-
mias (17).
Impact of the RV/LV pressure ratio on long-term survival.
Avoidance of an outflow tract patch would lead to the accep-
tance of higher postoperative systolic RV/LV pressure ratios.
Increased RV/LV pressure ratios after corrections are clearly a
risk factor for operative death, but the influence on long-term
survival remains as controversial as the outflow tract patch. In
contrast to the studies by Kirklin and Murphy, both Jonsson’s
study and our study could not show any influence of a high
pressure ratio on long-term survival. It might be explained by
a similar hypothesis that older, more hypertrophied hearts
could better tolerate a persistent pressure load.
Figure 9. Normal life expectancy in a subgroup of patients.
On multivariate analysis, only use of an outflow tract patch
and preoperative polycythemia were patient-dependent risk
factors. A comparison between a low risk group of patients
(no outflow tract patch and no preoperative polycythemia)
and an age- and gender-matched control group of the Bavar-
ian population shows no difference in long-term survival up to
35 years. Thus, subgroups may achieve normal life expectancy.
OP 5 operation.
Figure 8. Long-term survival according to the date of the
operation. Throughout the whole period, operative manage-
ment and techniques did not change. However, patients
operated on after 1970 showed improved long-term survival.
This has to be attributed to the growing experience of the
single surgeon. OP 5 operation.
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Impact of age on long-term survival. In contrast to most
other studies, older age was not associated with an increased
mortality risk. A striking explanation for this fact is lacking.
The number of older patients in our study is higher (Fig. 3)
than that in all other studies where age was found to be a risk
factor; completeness and length of follow-up add to the
statistical power of our analysis. The Mayo Clinic reported on
30 patients who had corrections at the age of $40 years (18).
Long-term survival was not different from that in a normal
age-matched control population, but was higher than that for
medically treated patients.
Impact of other risk factors on long-term survival. Multi-
variate analysis demonstrated increased HCT levels as an
additional risk. Data on preoperative polycythemia as an
incremental risk factor is disagreeing. Zhao et al. (19) could
not find any association between HCT and outcome, whereas
Kirklin et al. (20) shared our experience. However, the mean
HCT values in our study are higher than those reported by
Kirklin and Zhao (54% vs. 49%), which may in part explain the
differences.
Surgical experience has been identified as a risk factor for
operative mortality (21), but to the best of our knowledge, it
has never been tested as a risk factor for long-term survival. In
our patient group, it seems to be a strong predictor of late
death, although it cannot be excluded that perioperative
management improved in parallel with surgical skill and added
to better long-term outcome. However, this result further
encourages repair of complex congenital heart defects only by
experienced surgeons in high volume centers. Other postoper-
ative factors such as ventricular function, arrhythmias and
pulmonary insufficiency are likely to influence long-term sur-
vival in this patient group (6,9,12). Because of the retrospective
nature of this study, data on these important issues were not
available.
Interpretation of operative and 1-year survival. Indication,
surgical technique and operative mortality of the correction of
TOF have changed dramatically since the early days of cardiac
surgery (22–24). Operations were performed in older children,
and only insufficient cardioprotective measures were used. The
combination of TOF with other major heart malformations,
previous shunt operations and any other reason to prolong
ischemic arrest, leads to a significant increase in mortality
rates. Therefore, interpretation of risk factors for short-term
survival in this historic experience is of very limited value to
contemporary practice. However, the isolation of a PFO as a
beneficial factor in multivariate analysis encourages the widely
used practice of leaving it open during repair to allow right to
left decompression in case of postoperative, temporary RV
failure (25).
Coping with TOF. Suicide is a common cause of late death
reported in almost all of the large series. Lillehei et al. (1) and
Rosenthal et al. (26) attributed 10% of late deaths to suicide.
In our own study, two patients committed suicide and in two
other patients suicide was likely but not confirmed; their
deaths were classified as unknown cause. This high incidence
of suicide might be the most striking evidence that, after
successful repair, patients often have psychological problems
such as low self esteem, lack of confidence and concern about
performing physical activity (27,28). Baer et al. (29) demon-
strated that neurotic behavior can be avoided by repair early in
childhood. Psychological support should be considered as one
important aspect in long-term care.
Conclusions. Our results demonstrate that in older chil-
dren with very hypertrophied RVs, the most important factors
for long-term survival are avoidance of polycythemia and a RV
outflow patch, as well as an experienced surgeon. Adding data
from other studies of younger patients, repair early in life may
avoid some of the risks the older patients have to face. Despite
the fact that some patient subgroups may achieve normal life
expectancy, TOF remains a life-long disease that is not cured
by repair.
We greatly appreciate the technical and editorial assistance of Oliver Dewald,
MD (Clinic of Cardiac Surgery, University of Munich, Germany), Christine
Rader and Michele Ferratti (Clinic of Cardiac Surgery, Children’s Hospital,
Boston).
Figure 10. Occurrence of reoperations in long-term survi-
vors. Reoperations were performed in 42 long-term survivors
during follow-up. OP 5 operation.
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